# A Study of the Cardiac Effects of Danicopan in Healthy Adults

> **NCT05016206** · PHASE1 · COMPLETED · sponsor: **Alexion Pharmaceuticals, Inc.** · enrollment: 33 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Danicopan
- **DRUG:** Moxifloxacin-matching Placebo
- **DRUG:** Danicopan-matching placebo
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT05016206
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-26
- **Primary completion:** 2018-10-12
- **Final completion:** 2018-10-12
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2021-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05016206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05016206, "A Study of the Cardiac Effects of Danicopan in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05016206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*